Henlius Biomedical focuses on the development, production and commercialization of mAb biosimilar drugs, bio-betters and novel mAbs.
Business Model:
Revenue: $0
Employees: 51-500
Address: 1289 Yishan Road
City: Xuhui
State: shanghai municipality
Zip: 200233
Country: CN
Henlius Biomedical focuses on the development, production and commercialization of mAb biosimilar drugs, bio-betters and novel mAbs.
Contact Phone:
Contact Email:
Listed Exchange:
Hong Kong Stock Exchange
IPO Date:
9/18/2019
Ticker Symbol:
2696
IPO Price:
$6.34/share
Amount Raised:
$410M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2016 | Venture Round | 2 | - |
Korea Investment Partners Founder H Fund Korea Investment Partners Founder H Fund |
12/2017 | Venture Round | 4 | $190M |
Fosun Pharma Green Tomato Joyful Ascent ShenZhen GTJA Investment Group Fosun Pharma Green Tomato Joyful Ascent ShenZhen GTJA Investment Group |
9/2019 | IPO | $410M |
|
7/2018 | Venture Round | $0 |
CICC Green Tomato Loyal Valley Capital New China Capital Management CICC Green Tomato Loyal Valley Capital New China Capital Management |
7/2018 | Venture Round | 4 | $156M |
CICC Green Tomato Loyal Valley Capital New China Capital Management CICC Green Tomato Loyal Valley Capital New China Capital Management |
6/2016 | Venture Round | 2 | - |
Founder H Fund Korea Investment Partners Founder H Fund Korea Investment Partners |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|